Egypt's Minister of Higher Education and Scientific Research, Dr. Abdel Aziz Qansoua, announced the results of the largest study of complete genetic sequencing under the "Reference Genome Project for Egyptians and Ancient Egyptians." The study included 1,024 Egyptian citizens representing 21 governorates and successfully identified approximately 17 million unique genetic variations that were not previously recorded in global databases.
These results serve as a national genetic reference for Egypt, ending decades of absence of Egyptian genetic representation in international research. Qansoua explained that this study will assist specialists in understanding the genetic nature of the Egyptian population and clarify the reasons behind the differences in bodily responses to diseases and medications compared to other populations.
Event Details
Dr. Khaled Amer, the principal investigator of the project, revealed that the study identified the prevalence rates of mutations causing 13 genetic diseases, including familial Mediterranean fever, where 1 in 11 Egyptians carry the disease mutation. Amer emphasized that relying on European metrics to predict diseases may lead to inaccurate results for Egyptians, highlighting the importance of a "national calibration" for global genetic risk models.
Dr. Ahmed Mustafa, head of the bioinformatics department at the center, noted that the research team demonstrated that global standards are insufficient to ensure medical accuracy, stressing the necessity of having the Egyptian genetic fingerprint in databases to enhance public health.
Background & Context
This study comes amid a scientific revolution in biology that has unfolded since the mid-20th century, opening the doors to a new era based on diagnosing diseases and prescribing appropriate treatments according to genetic makeup. This shift reflects a change in medical diagnostic strategies and drug production, moving from a one-size-fits-all approach to medications tailored to individual health conditions.
This study is a significant step towards achieving personalized medicine, which relies on the genetic code of each citizen, contributing to improving the quality of healthcare in Egypt.
Impact & Consequences
The results of the study confirm a clear genetic affinity between Egyptians and populations in the Middle East, estimated at 71.8%, particularly with the genetic groups of Bedouins, Yemenis, and Saudis. This affinity opens the door to a deeper understanding of the shared genetic factors among these peoples.
Furthermore, the findings indicate the need to reconsider how global genetic data is utilized, as the representation of Middle Eastern and North African populations in current databases is limited, necessitating further studies to update this data.
Regional Significance
This study represents a turning point in the field of medicine and scientific research in the Arab world, enhancing the ability of countries to conduct precise genetic research that reflects the genetic diversity in the region. It also opens new horizons for cooperation among Arab countries in scientific research.
In conclusion, the Egyptian Genome Project not only represents a scientific achievement but also reflects Egypt's commitment to advancing public health and scientific research, contributing to improving the quality of life for its citizens.